期刊文献+

鄞州区结核分枝杆菌耐药性研究 被引量:4

Drug resistance analysis of mycobacterium tuberculosis in Yinzhou district
原文传递
导出
摘要 目的了解鄞州区肺结核患者结核分枝杆菌的耐药水平,为本区的结核病诊治提供参考依据。方法对鄞州区疾病预防控制中心2008—2009年收集的结核分枝杆菌用WHO推荐的比例法进行异烟肼(H)、利福平(R)、链霉素(S)和乙胺丁醇(E)的耐药性检测。结果 299例初复治患者的痰培养分离的结核分枝杆菌,总耐药率为30.77%,初始耐药率和获得性耐药率分别为27.48%和54.05%;耐多药率为6.69%,其中初始和获得性耐多药率分别为4.20%和24.32%。4种抗结核药物的耐药率由高到低分别为异烟肼(19.40%)、链霉素(16.05%)、利福平(9.36%)和乙胺丁醇(6.02%)。不同性别、年龄、户籍的耐药率差异无统计学意义。结论鄞州区结核病耐药形势依然严峻,应继续加强结核病的防治工作。 Objective To explore the drug resistance level of Mycobacterium tuberculosis (MTB) ,and to pn)vidc evidencc for the control of tubcrculosis(TB). Methods Proportion method was uscd for drug susceptibility testing of isuniazid ( INH), rifampicin (RFP) , streptomycin (SM) and cthambutol (EMB) according to the WtlO guidelines for Surveillance of Drug Resistance in Tuberculosis. Results The resistant rate to any drug was 30.77% in all MTB isolatcs, according to cases of 299 sputum culture of Mycobactcfium tuberculosis, 27.5% in 262 new cases and 54. 1% in 37 previously treated cases, respectively. Multi - drug rcsistant rate (MI)R) was 6.7%. Initial and acquired MDR was 4. 2% and 24.3% ,respectively. Drug resistance rate of 1Ntt, SM, RFP, and EMI3 from high to low was 19.4%, 16. 1%, 9.4% and 6.0%, respectively. The drug resistance rate did not show significant differencc among different gcndcrs, age and domicile groups ( P〉 0. 05 ). Conclusion The results show that thc situation of TB drug - resistance is severe in Yinzhou district of Ningbo City. The prevention and control of TB should be strengthened.
出处 《浙江预防医学》 2011年第3期9-11,15,共4页 Zhejiang Journal of Preventive Medicine
基金 宁波市鄞州区2009年度第二批科技项目(鄞科〔2009〕61号)
关键词 结核分枝杆菌 耐药性 监测 Mycobacterium tuberculosis Drug - resistance Survcillancc
  • 相关文献

参考文献5

二级参考文献30

  • 1安燕生,丁北川,朱建华,邢青,贺晓新,靳敏芝,罗平,王甦民.北京市WHO结核病药物耐药性监测研究[J].中国防痨杂志,2007,29(6):475-478. 被引量:22
  • 2Nachega JB, Chaisson RE. Tuberculosis drug resistance : a global threat [J]. Clin Infect Dis, 2003, 36(Suppl 1) : S24 -30.
  • 3Aziz MA, Wright A, Laszlo A, De Muynck A, Portaels F, Van Deun A, Wells C, Nunn P, Blanc L, Raviglione M; WHO/International Union Against Tuberculosis And Lung Disease Global Project on Anti-tuberculosis Drug Resistance Surveillance. Epidemiology of antituberculosis drug resistance (the Global Project on Anti-tuberculosis Drug Resistance Surveillance): an updated analysis[J]. Lancet, 2006, 368:2142--2154.
  • 4Maher D, Raviglione M. Global epidemiology of tuberculosis[J].ClinChest Med, 2005,26(2):167--182.
  • 5Namaei MH, Sadeghian A, Naderinasab M, Ziaee M. Prevalence of primary drug resistant Mycobacterium tuberculosis in Mashhad, Iran [J]. IndianJ MedRes, 2006,124(1):77--80.
  • 6Rao NA, Irfan M, Hussain SJ. Primary drug resistance against Mycobacterium tuberculosis in Karachi [J].J Pak Med Assoc, 2008,58(3) : 122-- 125.
  • 7Yew WW, Leung CC. Management of multidrug-resistant tuberculosis: update 2007 [J]. Respirology,2008,13(1) ;21--46.
  • 8Lew W, Pai M, Oxlade O, Martin D, Menzies D. Initial drug resistance and tuberculosis treatment outcomes: systematic review and recta-analysis [J]. Ann Intern Med, 2008,149(2) :123 --134.
  • 9Watterson SA, Wilson SM, Yates MD, Drobniewski FA. Comparison of three molecular assays for rapid detection of rifampin resistance in Mycobacterium tuberculosis [J]. J Clin Microbiol, 1998,36(7) : 1969-- 1973.
  • 10王甦民,刘宇红,姜广路,刘洋,付育红,端木宏谨.世界卫生组织中国结核病耐药监测的结果评价[J].中华检验医学杂志,2007,30(8):863-866. 被引量:48

共引文献69

同被引文献16

引证文献4

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部